Pheronym Milestones Are Recognized by Society of Invertebrate Pathology
UF Innovate | The Hub and UF Innovate | Sid Martin Biotech alum Pheronym, a bio-ag-tech pest control company, has been selected as Research Highlights in the past two years by the Society of Invertebrate Pathology (SIP), Division of Nematodes for the company’s technical milestones. The paper “Conspecific and Heterospecific Pheromones Stimulate Dispersal of Entomopathogenic […]
Morphogenis and USF Health Form Clinical Research Partnership
USF Health has partnered with UF startup and UF Innovate | Sid Martin Biotech alumn Morphogenesis, Inc., a biotechnology company developing immunotherapies for cancer patients, on a two-year contract that runs the gamut. The affiliation agreement will allow for clinical and clinical research collaborations, opportunities for students to intern for Morphogenesis, and the company will […]
Axogen Recon Clinical Study Completes Target Enrollment of 220 Subjects
UF Innovate | Sid Martin Biotech alum AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, announced that its phase 3 pivotal RECONSM Clinical Study supporting its Biologics License Application (BLA) submission for Avance Nerve Graft has reached its enrollment target of 220 subjects. RECON […]
AGTC Announces Updated Development Plan for Its X-Linked Retinitis Pigmentosa Clinical Program
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced next steps in the clinical development of the company’s potential treatment of X-linked retinitis pigmentosa (XLRP) caused by mutations in […]
Harvard’s Tough Gel Technology Licensed to Amend Surgical for Oral Surgery Applications
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced that its tough gel adhesive technology has been licensed by UF Innovate | Sid Martin Biotech alum Amend Surgical, a Florida-based medical device company focused on developing and manufacturing novel biomaterials. Through a licensing agreement coordinated by Harvard’s Office of Technology Development (OTD), Amend […]
Montagu Private Equity LLP Completes Acquisition of the RTI Surgical OEM Business
Montagu Private Equity LLP, a leading European private equity firm, announced the completion of its acquisition of UF startup and UF Innovate | Sid Martin Biotech alum RTI Surgical OEM business. Following the acquisition, the OEM business will operate as a standalone company and retain the RTI Surgical name. The new RTI Surgical will further […]
Tiny Florida Medical Research Firm Faces Giant Challenge — COVID-19 Vaccine
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a Tampa-based medical research business with roots in Gainesville, found itself at a crossroads earlier this year right before the COVID-19 pandemic struck America. The company’s previous project had been working on modifying genes related to bacteria in the hopes of stopping oral mucositis in […]
Oragenics Provides Update on SARS-CoV-2 (COVID-19) Program
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, provided an update on progress with its SARS-CoV-2 (COVID-19) vaccine candidate and announced the termination of its clinical development program with AG013 for the treatment of severe oral […]
Ology Bioservices Wins Three Department of Defense Awards Totaling More Than $16 Million
UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced that the Department of Defense (DOD), through the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA), has awarded the company with three biomanufacturing contracts with a combined value of […]
AGTC Boosts AAV Manufacturing Productivity With Herpes Simplex Virus
By using the herpes simplex virus (HSV) as a helper for its adeno-associated viral (AAV) platform UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC) created AAVs that are more robust, purer and lower cost than any of the other methods. Its gene therapy program for X-linked retinitis pigmentosa […]